A. Friedman

发表

Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

J. Ulmer, J. Donnelly, T. Fu, 1998, Journal of Virology.

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

J. Shiver, J. Ulmer, J. Donnelly, 1995, Nature Medicine.

Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

J. Ulmer, J. Donnelly, T. Fu, 1997, Molecular medicine.

Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.

J. Ulmer, J. Donnelly, T. Fu, 1999, Journal of immunology.

DNA vaccines for bacteria and viruses.

J. Ulmer, J. Donnelly, R. Deck, 1996, Advances in experimental medicine and biology.

Influenza Virus Challenge Correlation with Protective Immunity Against Frequency Induced by a DNA Vaccine and Dose Dependence of CTL Precursor

J. Ulmer, J. Donnelly, T. Fu, 1999 .

Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.

J. Ulmer, J. Donnelly, T. Fu, 1998, Vaccine.

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

J. Shiver, K. Leander, J. Ulmer, 1993, DNA and cell biology.

Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

R. K. Evans, W. Mcclements, D. Volkin, 1999, Vaccine.

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.

J. Shiver, K. Leander, J. Ulmer, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Pore formation and mitogenicity in blood cells by the class 2 protein of Neisseria meningitidis.

J. Ulmer, J. Donnelly, A. Friedman, 1992, The Journal of biological chemistry.

A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

J. Donnelly, R. Deck, A. Friedman, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

J. Ulmer, J. Donnelly, R. Deck, 1994, Vaccine.

Induction of immunity by DNA vaccination: application to influenza and tuberculosis.

I. Orme, J. Ulmer, J. Donnelly, 1997, Behring Institute Mitteilungen.

Heterologous protection against influenza by injection of DNA encoding a viral protein.

J. Ulmer, J. Donnelly, P. Felgner, 1993, Science.

Hyperpotentiation by Synthetic Double-Stranded RNA of Antibody Responses to Influenza Virus Vaccine in Adjuvant 65

M. Hilleman, A. Friedman, A. Woodhour, 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Sex-related differences in immune response and survival rate of broiler chickens.

G. Leitner, E. D. Heller, A. Friedman, 1989, Veterinary immunology and immunopathology.

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

J. Ulmer, J. Donnelly, T. Fu, 1997, Journal of virology.

Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice.

J. Ulmer, J. Donnelly, A. Friedman, 1998, Vaccine.

Immunological parameters in meat-type chicken lines divergently selected by antibody response to Escherichia coli vaccination.

G. Leitner, Z. Uni, E. D. Heller, 1992, Veterinary immunology and immunopathology.

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination.

J. Ulmer, J. Donnelly, A. Friedman, 1997, Vaccine.

New metabolizable immunologic adjuvant for human use. X. Long-term serologic and clinical follow-up.

M. Hilleman, A. Friedman, R. Weibel, 1970, The American journal of medicine.

Studies for safety of adjuvant 65.

M. Hilleman, A. Friedman, A. Woodhour, 1972, Annals of allergy.

Ten-Year Follow-Up Study for Safety of Adjuvant 65 Influenza Vaccine in Man

M. Hilleman, A. Friedman, A. Mclean, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

T. Fu, R. Deck, A. Friedman, 1997, Molecular medicine.